Daily Stock Analysis, FLDM, Fluidigm Corp, priceseries

Fluidigm Corp. Daily Stock Analysis
Stock Information
Open
5.51
Close
5.56
High
5.64
Low
5.43
Previous Close
5.51
Daily Price Gain
0.05
YTD High
14.90
YTD High Date
Mar 20, 2019
YTD Low
5.06
YTD Low Date
Aug 28, 2019
YTD Price Change
-3.03
YTD Gain
-35.27%
52 Week High
14.90
52 Week High Date
Mar 20, 2019
52 Week Low
5.06
52 Week Low Date
Aug 28, 2019
52 Week Price Change
-2.79
52 Week Gain
-33.41%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Aug 24. 2017
3.67
Sep 19. 2017
4.99
17 Trading Days
35.98%
Link
LONG
Nov 20. 2017
5.19
Dec 4. 2017
5.66
9 Trading Days
8.98%
Link
LONG
Feb 9. 2018
6.58
Feb 22. 2018
7.06
8 Trading Days
7.35%
Link
LONG
Aug 22. 2018
7.09
Sep 7. 2018
7.59
11 Trading Days
7.10%
Link
LONG
Dec 24. 2018
7.90
Jan 14. 2019
8.68
13 Trading Days
9.87%
Link
LONG
Feb 8. 2019
9.35
Mar 26. 2019
13.58
31 Trading Days
45.23%
Link
Company Information
Stock Symbol
FLDM
Exchange
NasdaqGS
Company URL
http://www.fluidigm.com
Company Phone
6502666000
CEO
Stephen Christopher Linthwaite
Headquarters
California
Business Address
7000 SHORELINE COURT, SUITE 100, SOUTH SAN FRANCISCO, CA 94080
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001162194
About

Fluidigm Corp. develops, manufactures, and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Description

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 system; integrated fluidic circuits (IFCs) consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. The company also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules. It serves academic institutions; clinical research laboratories; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations. Fluidigm Corporation distributes its systems through direct sales force and support organizations located in North America, Europe, and the Asia-Pacific, and through distributors or sales agents in various European, Latin American, Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.